Welcome to our dedicated page for WW International news (Ticker: WW), a resource for investors and traders seeking the latest updates and insights on WW International stock.
WW International, Inc. operates the Weight Watchers weight-management platform through digital, workshop and clinical subscription offerings. Company news commonly covers subscriber trends, subscription revenue, adjusted operating measures and the balance between its Behavioral business and its Clinical business.
Recurring updates also include expansion of the Med+ clinical offering, access to FDA-approved GLP-1 treatment options through affiliated medical groups, debt-reduction actions involving its term loan, and governance changes such as board appointments, committee assignments and interim executive-leadership structure.
WW International (WW) appointed Stephen Bye as President and Chief Executive Officer and to its Board of Directors, with his appointment effective this fall.
Bye most recently served as President and CEO of Ookla, where he transformed and scaled the connectivity intelligence business, growing subscription revenue and improving operational efficiency and profitability while integrating multiple acquisitions. The Weight Watchers board highlights his experience in consumer subscription and product businesses, leading companies through industry disruption, and driving profitable growth and shareholder value.
With more than 30 years of leadership across major communications and technology companies, Bye is expected by the company to help advance Weight Watchers’ strategy of building an integrated weight health platform for the GLP-1 era that combines behavioral support, clinical care and access to GLP-1 medications with technology and data-driven personalization.
Weight Watchers (WW) will participate in the Morgan Stanley Annual Global Healthcare Conference on Tuesday, September 15, 2026. The company will host a fireside chat starting at 2:35 p.m. ET, which will focus on its science-backed weight management approach and healthcare positioning.
The fireside chat will be available via live audio webcast on the corporate website at corporate.ww.com under the Events and Presentations section. A replay of the webcast will be accessible on the site for at least 90 days. Weight Watchers highlights its integrated support system for the GLP-1 era, combining scientific expertise, medication, technology, and human support across consumer and business channels.
Weight Watchers (Nasdaq: WW) reported Q2 2026 revenue of $162.3 million, including $39.9 million in Clinical Subscription Revenue, up 30.4% year-over-year. Total end-of-period subscribers were 2.5 million, with Clinical subscribers of 197 thousand, up 55.7% year-over-year, and Core+ Behavioral subscribers of 541 thousand, up 13.9%, marking a third consecutive quarter of sequential growth.
Q2 Monthly Subscription ARPU increased 10.2% year-over-year. Gross margin was 70.3% and Adjusted Gross Margin 73.6%. Marketing expense was $47.9 million, or 29.5% of revenue. Net income was $14.1 million and Adjusted EBITDA $39.8 million. Operating cash flow reached $24.3 million, with cash of $101.5 million at June 30, 2026. The company prepaid $36.8 million on its term loan, cutting principal by $41.4 million and annualized interest by about $4 million, and reaffirmed full-year 2026 revenue guidance of $620–$635 million and Adjusted EBITDA of $105–$115 million.
Weight Watchers (NASDAQ: WW) plans to release its second quarter 2026 results, for the period ended June 30, 2026, after market close on Wednesday, August 5, 2026. The company will host an earnings conference call at 5:00 p.m. ET, with a live webcast and a replay available for at least 90 days on its corporate website.
Weight Watchers (NASDAQ:WW) announced a collaboration with Sam’s Club to expand affordable, holistic wellness options for Sam’s Club members.
Sam’s Club Plus members may receive a complimentary three-month Weight Watchers Core membership, then continue for $10 per month, while all members get up to 50% off select WW programs, including Core+ and Med+ with GLP-1 support and integrated pharmacy services.
Weight Watchers (NASDAQ: WW) and FlavCity announced a summer collaboration centered on strength, nutrition, and community. The partnership introduces a limited-edition Whipped Lemonade protein smoothie powder with 25g protein, 10g collagen, no artificial flavors, and a 4 Points value, sold via FlavCity’s TikTok Shop and website.
Alongside the product, Weight Watchers launched Summer Strength Club, a 10-week experience with live Friday strength classes led by Global Strength Coach Holly Rilinger, nutrition content featuring the new flavor, recipes, coaching, and an in-app community challenge for members and non-members.
Weight Watchers (NASDAQ:WW) announced that Weight Watchers Med+ will support Medicare beneficiaries accessing GLP-1 medications via the Medicare GLP-1 Bridge Program.
Eligible members with Medicare Part D can obtain select GLP-1 weight-loss drugs for $50 per month from July 1, 2026 through December 31, 2027, alongside Med+ clinical and behavioral support.
According to Weight Watchers, Med+ members on GLP-1s who engaged with the GLP-1 Success Program lost 29.1% more body weight at 12 months, and 73% reported that Med+ helps minimize medication side effects.
Weight Watchers (NASDAQ: WW) is supporting the American Heart Association’s Healthy Living BEYOND Weight™ Study, a nationwide research effort on real-world weight and health experiences. The collaboration engages WW members, including GLP-1 users, to help evaluate long-term outcomes across medical, surgical, and lifestyle weight-management pathways.
Weight Watchers highlights data showing Med+ members on GLP-1s who regularly used behavioral support lost 61.3% more body weight at 1 month and 29.1% more at 12 months than those without such support, underscoring the role of integrated medical and behavioral care.
Weight Watchers (Nasdaq: WW) and CheqUp are expanding their UK partnership to integrate behavioural and clinical weight management. CheqUp becomes the dedicated partner for medical weight-loss treatment, while UK members gain streamlined access to CheqUp consultations plus the Weight Watchers app, Core+ plan and GLP-1 Companion Programme.
According to Weight Watchers, 85% of GLP-1 Companion Programme U.S. members say it makes getting healthy easier and 81% call Weight Watchers the perfect partner on their GLP-1 journey.
Weight Watchers (NASDAQ: WW) is now accessible through Eli Lilly’s digital platform LillyDirect, allowing LillyDirect customers to connect to the Weight Watchers Med+ GLP-1 program. The integrated model combines prescription weight management, clinical care, and behavioral, nutrition, and community support across the full weight health journey.